Search research articles
Contact Us
Filters
Showing results (91-100 of 127) with videos related to
Page
of 13
Sort By:
Communications Biology
|
June 11, 2021
Macropinocytosis requires Gal-3 in a subset of patient-derived glioblastoma stem cells
Laetitia Seguin, Soline Odouard, Francesca Corlazzoli, et al.
Digestive Diseases and Sciences
|
December 21, 2016
Adalimumab Maintenance Treatment in Ulcerative Colitis: Outcomes by Prior Anti-TNF Use and Efficacy of Dose Escalation
Carlos Taxonera, Eva Iglesias, Fernando Muñoz, et al.
Gastroenterologia Y Hepatologia
|
June 15, 2021
Non-pharmacologic direct cost of a simplified strategy with glecaprevir/pibrentasvir for 8 weeks in naïve non-cirrhotic patients with hepatitis C implemented in clinical practice. The Just SIMPLE Study
Juan Turnes, Diego Rincón, José L Calleja, et al.
Gastroenterologia Y Hepatologia
|
December 13, 2024
Position statement of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis on the use of Telemedicine in Inflammatory Bowel Disease
Mariam Aguas Peris, Javier Del Hoyo Francisco, Pilar Nos Mateu, et al.
Scientific Reports
|
October 21, 2020
Real-life experience with 4 years of golimumab persistence in ulcerative colitis patients
Marisa Iborra, Natalia García-Morales, Saoia Rubio, et al.
Frontiers in Immunology
|
October 9, 2025
Correction: Recurrent reproductive failure and celiac genetic susceptibility, a leading role of gluten
Eduardo de la Fuente-Munoz, Miguel Fernández-Arquero, Nabil Subhi-Issa, et al.
Inflammatory Bowel Diseases
|
July 4, 2017
Clinical Outcomes of Golimumab as First, Second or Third Anti-TNF Agent in Patients with Moderate-to-Severe Ulcerative Colitis
Carlos Taxonera, Cristina Rodríguez, Federico Bertoletti, et al.
Frontiers in Immunology
|
November 8, 2024
Recurrent reproductive failure and celiac genetic susceptibility, a leading role of gluten
Eduardo de la Fuente-Munoz, Miguel Fernández-Arquero, Nabil Subbhi-Issa, et al.
Digestive Diseases and Sciences
|
June 6, 2015
Infliximab Dose Escalation as an Effective Strategy for Managing Secondary Loss of Response in Ulcerative Colitis
Carlos Taxonera, Manuel Barreiro-de Acosta, Marta Calvo, et al.
Medwave
|
June 26, 2025
Descriptive analysis of immunological abnormalities in recurrent reproductive failure and therapeutical outcomes
Eduardo de la Fuente-Muñoz, Nabil Subhi-Issa, Ángela Villegas Mendiola, et al.
Page
of 13
Search research articles
Search
Showing results (91-100 of 127) with videos related to
Sort By:
Page
of 13
Communications Biology
|
June 11, 2021
Macropinocytosis requires Gal-3 in a subset of patient-derived glioblastoma stem cells
Laetitia Seguin, Soline Odouard, Francesca Corlazzoli, et al.
Digestive Diseases and Sciences
|
December 21, 2016
Adalimumab Maintenance Treatment in Ulcerative Colitis: Outcomes by Prior Anti-TNF Use and Efficacy of Dose Escalation
Carlos Taxonera, Eva Iglesias, Fernando Muñoz, et al.
Gastroenterologia Y Hepatologia
|
June 15, 2021
Non-pharmacologic direct cost of a simplified strategy with glecaprevir/pibrentasvir for 8 weeks in naïve non-cirrhotic patients with hepatitis C implemented in clinical practice. The Just SIMPLE Study
Juan Turnes, Diego Rincón, José L Calleja, et al.
Gastroenterologia Y Hepatologia
|
December 13, 2024
Position statement of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis on the use of Telemedicine in Inflammatory Bowel Disease
Mariam Aguas Peris, Javier Del Hoyo Francisco, Pilar Nos Mateu, et al.
Scientific Reports
|
October 21, 2020
Real-life experience with 4 years of golimumab persistence in ulcerative colitis patients
Marisa Iborra, Natalia García-Morales, Saoia Rubio, et al.
Frontiers in Immunology
|
October 9, 2025
Correction: Recurrent reproductive failure and celiac genetic susceptibility, a leading role of gluten
Eduardo de la Fuente-Munoz, Miguel Fernández-Arquero, Nabil Subhi-Issa, et al.
Inflammatory Bowel Diseases
|
July 4, 2017
Clinical Outcomes of Golimumab as First, Second or Third Anti-TNF Agent in Patients with Moderate-to-Severe Ulcerative Colitis
Carlos Taxonera, Cristina Rodríguez, Federico Bertoletti, et al.
Frontiers in Immunology
|
November 8, 2024
Recurrent reproductive failure and celiac genetic susceptibility, a leading role of gluten
Eduardo de la Fuente-Munoz, Miguel Fernández-Arquero, Nabil Subbhi-Issa, et al.
Digestive Diseases and Sciences
|
June 6, 2015
Infliximab Dose Escalation as an Effective Strategy for Managing Secondary Loss of Response in Ulcerative Colitis
Carlos Taxonera, Manuel Barreiro-de Acosta, Marta Calvo, et al.
Medwave
|
June 26, 2025
Descriptive analysis of immunological abnormalities in recurrent reproductive failure and therapeutical outcomes
Eduardo de la Fuente-Muñoz, Nabil Subhi-Issa, Ángela Villegas Mendiola, et al.
Page
of 13